Structure Therapeutics, Inc. (GPCR)
17.36
-0.81
(-4.46%)
USD |
NASDAQ |
Nov 18, 16:00
17.43
+0.07
(+0.40%)
After-Hours: 20:00
Structure Therapeutics Total Liabilities (Quarterly) : 112.55M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 112.55M |
| June 30, 2026 | 71.01M |
| March 31, 2026 | 61.03M |
| December 31, 2025 | 67.54M |
| September 30, 2025 | 62.14M |
| June 30, 2025 | 44.36M |
| March 31, 2025 | 41.91M |
| December 31, 2024 | 38.49M |
| September 30, 2024 | 36.42M |
| June 30, 2024 | 26.00M |
| Date | Value |
|---|---|
| March 31, 2024 | 27.41M |
| December 31, 2023 | 29.05M |
| September 30, 2023 | 23.41M |
| June 30, 2023 | 15.01M |
| March 31, 2023 | 11.00M |
| December 31, 2022 | 13.01M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 8.930M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 107.80B |
| Novo Nordisk A/S | 57.94B |
| Merck & Co., Inc. | 87.83B |
| Prestige Consumer Healthcare, Inc. | 2.777B |
| Pfizer Inc. | 115.24B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.334B |
| Shareholders Equity (Quarterly) | 1.222B |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 11.91 |
| Net Debt Paydown Yield | 0.01% |